Skip to content

Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress.

Kevin T Krupp, Jazmine D W Yaeger, Leighton J Ledesma, Miyuraj Harishchandra Hikkaduwa Withanage, J J Gale, Chase B Howe, Trevor J Allen, Monica Sathyanesan, Samuel S Newton, Cliff H Summers

Neuropharmacology July 1, 2024 DOI: 10.1016/j.neuropharm.2024.109949 (opens in new tab)

Read Full Text
Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study Peer reviewed
Population Male mice
Intervention (R)-DOI
Dose low doses
Duration Single administration
Topics Anxiety Depression PTSD
Keywords Defeat Fear conditioning Freezing Hypocretin Locomotion Neuroinflammation Psychedelic Resilience Stress-alternatives model Susceptibility
Citations 11
Key findings A single low dose of (R)-DOI increases stress-coping behaviors and reduces plasma and brain levels of the inflammatory cytokine TNFα in male mice exposed to repeated social aggression.

Abstract

Psychedelic compounds have potentially rapid, long-lasting anxiolytic, antidepressive and anti-inflammatory effects. We investigated whether the psychedelic compound (R)-2,5-dimethoxy-4-iodoamphetamine [(R)-DOI], a selective 5-HT2A receptor partial agonist, decreases stress-related behavior in male mice exposed to repeated social aggression. Additionally, we explored the likelihood that these behavioral changes are related to anti-inflammatory properties of [(R)-DOI]. Animals were subjected to the Stress Alternatives Model (SAM), an escapable social stress paradigm in which animals develop reactive coping strategies - remaining in the SAM arena (Stay) with a social aggressor, or dynamically initiated stress coping strategies that involve utilizing the escape holes (Escape) to avoid aggression. Mice expressing these behavioral phenotypes display behaviors like those in other social aggression models that separate animals into stress-vulnerable (as for Stay) or stress-resilient (as for Escape) groups, which have been shown to have distinct inflammatory responses to social stress. These results show that Stay animals have heightened cytokine gene expression, and both Stay and Escape mice exhibit plasma and neural concentrations of the inflammatory cytokine tumor necrosis factor-α (TNFα) compared to unstressed control mice. Additionally, these results suggest that a single administration of (R)-DOI to Stay animals in low doses, can increase stress coping strategies such as increasing attention to the escape route, promoting escape behavior, and reducing freezing during socially aggressive interaction in the SAM. Lower single doses of (R)-DOI, in addition to shifting behavior to suggest anxiolytic effects, also concomitantly reduce plasma and limbic brain levels of the inflammatory cytokine TNFα.

Comparable studies

Other preclinical and animal studies on PTSD, most cited first.

Study Year Design Participants
Pharmahuasca and DMT Rescue ROS Production and Differentially Expressed Genes Observed after Predator and Psychosocial Stress: Relevance to Human PTSD. Rats exposed to a 30-day stress regimen 2022 Preclinical animal study with in vitro assays
Ketamine ameliorates post-traumatic social avoidance by erasing the traumatic memory encoded in VTA-innervated BLA engram cells. Mice 2024 Experimental animal study
Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors Male and female mice 2024 Experimental study
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD. Rats 2024 Animal study
Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder. Male rats 2024 Preclinical study

Citations in the library

Cited by 6

and 1 more in the library

Cites 45

and 40 more in the library

Related reading

Explore topics

Anxiety Depression PTSD Serotonin